Houlton M C, Marivate M, Philpott R H
Br J Obstet Gynaecol. 1981 Mar;88(3):264-73. doi: 10.1111/j.1471-0528.1981.tb00980.x.
A total of 132 twin pregnancies first seen at less than 36 weeks gestation were studied prospectively to determine the epidemiological and anthropomorphic factors associated with single or dual fetal growth retardation; the clinical, biochemical and ultrasound serial measurements that are predictive of single or dual fetal growth retardation, and to design scoring systems for the prediction of fetal growth retardation. A number of factors were associated with an increased risk of fetal growth retardation, but the highest risk was present when there was an abnormality in both plasma oestriol and placental lactogen, and the biparietal diameter growth rates were divergent. Scoring systems were derived using multi-variant discriminant analysis for three clinical situations: the patient seen for the first or second time; where only clinical facilities exist and the patient was seen on three or more occasions; and where facilities exist for the biochemical tests of placental function and ultrasonic measurement of the biparietal diameters. The scoring system for the last situation had the highest predictive rate and the lowest false positive rate.
对132例妊娠小于36周初诊的双胎妊娠进行前瞻性研究,以确定与单胎或双胎胎儿生长受限相关的流行病学和人体测量学因素;预测单胎或双胎胎儿生长受限的临床、生化和超声系列测量方法,并设计预测胎儿生长受限的评分系统。许多因素与胎儿生长受限风险增加有关,但当血浆雌三醇和胎盘催乳素均异常且双顶径生长速率不同时,风险最高。使用多变量判别分析得出三种临床情况的评分系统:首次或第二次就诊的患者;仅具备临床检查条件且患者就诊三次或更多次的情况;具备胎盘功能生化检测和双顶径超声测量条件的情况。最后一种情况的评分系统预测率最高,假阳性率最低。